Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations

British Journal of Dermatology

Volumn 134, Issue 2, 1996, Pages 276-281

  Anagnostopoulos, I ^a   Hummel, M ^a   Kaudewitz, P ^b   Korbjuhn, P ^a   Leoncini, L ^c   Stein, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0030058009     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07613.x     Document Type: Article

References (26)

1. Wood GS. Benign and malignant cutaneous lymphoproliferative disorders including mycosis fungoides. In: Neoplastic Hematopatholgy (Knowles D ed.). Baltimore; Williams & Wilkins, 1992; 675-714.
2. Sterry W, Mielke V. CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T-cells (CD45RA-, CDw29+). J Invest Dermatol 1989; 93: 413-16.
3. +) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical characteristics. Am J Pathol 1989; 135: 359-67.
4. Kadin ME. The spectrum of Ki-1+ cutaneous lymphomas. In: Current Problems in Dermatology (van Vloten WA, Willemze R, Veljsgaard DL, Thomsen K, eds), Vol. 19, London: Karger, 1990; 132-43.
5. Lee PYP, Charley M, Tharp M et al. Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas. J Invest Dermatol 1990; 95: 309-12.
6. Anagnostopoulos I, Hummel M, Finn T et al. Heterogeneous Epstein-Barr-virus infection patterns in peripheral T cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992; 80: 1804-12.
7. Korbjuhn P, Anagnostopoulos I, Hummel M et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in HIV negative European peripheral pleomorphic T cell lymphomas. Blood 1993; 82: 217-23.
8. Anagnostopoulos I, Hummel M, Tiemann M et al. Frequent presence of Epstein-Barr virus infection in lymphoepithelioid cell (Lennert's) lymphoma. Histopathology 1994; 25: 331-7.
9. Fischer E, Delibrias K, Kazachkine MD. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 1991; 146: 865-9.
10. Hummel M, Anagnostopoulos I, Dallenbach F et al. EBV infection patterns in Hodgkin's disease and normal lympoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689-94.
11. Herbst H, Dallenbach F, Hummel M et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991; 78: 1-10.
12. Howe JG, Steitz JA. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 1986; 83: 9006-10.
13. Kieff E, Liebowitz D. Epstein-Barr virus and its replication. In: Virology (Fields BN, Knipe DM, eds), 2nd edn. New York: Raven Press, 1990; 1889-920.
14. Rowe M, Evans HS, Young LS et al. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 1987; 68: 1575-86.
15. Young L, Alfieri C, Hennessy K et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-5.
16. Cordell LL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-29.
17. Weiss LM, Chen Y-Y, Liu X-F, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridisation and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65.
18. Gilligan K, Rajadurai P, Resnik L, Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 1990; 87: 8790-4.
19. MacKie RM. Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells. Lancet 1981; 327: 283-5.
20. Slater DN, Rooney N, Bleehen S, Hamed A. The lymph node in mycosis fungoides: a light and electron microscopy and immunohistological study supporting the Langerhans cell-retrovirus hypothesis. Histopathology 1985; 6: 587-621.
21. Dreno B, Celerier P, Fleischmann M et al. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome. Acta Derm Venereol (Stockh) 1994; 74: 355-7.
22. Kadin ME, Vonderheid, Weiss LM. Absence of EBV-RNA in lymphomatoid papulosis. J Pathol 1993; 170: 145-8.
23. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 1995; 175: 263-71.
24. Slater D. Epstein-Barr virus: an etiological factor in cutaneous lymphoproliferative diseases? J Pathol 1991; 165: 1-4 (Editorial).
25. Anagnostopoulos I, Hummel M, Kaudewitz P et al. Detection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphoma. Am J Pathol 1990; 137: 1317-22.
26. Lange-Wantzin G, Thomsen K, Nissen NI et al. Occurrence of human T cell lymphotropic virus (type 1) in cutaneous T cell lymphoma. J Am Acad Dermatol 1986; 15: 598-602.